Skip to contentHURWITZ EDWARD — MACROGENICS INC insider: 136 transactions · InsiderLensHURWITZ EDWARD
- 10% owner at THRESHOLD PHARMACEUTICALS INC · on record since Sep 5, 2008
- 10% owner at AXONYX INC · on record since Oct 5, 2006
- Nolonger 10% Owner at COTHERIX INC · on record since Jan 9, 2007
- 10% owner at NeurogesX Inc · on record since May 8, 2007
- Director at SUNESIS PHARMACEUTICALS INC · on record since Jun 19, 2009
- 10% owner at SUNESIS PHARMACEUTICALS INC · on record since Apr 7, 2009
- No longer 10% owner at AXONYX INC · on record since Sep 8, 2009
- Former 10% owner at THRESHOLD PHARMACEUTICALS INC · on record since Oct 6, 2009
- 10% owner at Aegerion Pharmaceuticals, Inc. · on record since Oct 27, 2010
- Director at MACROGENICS INC · on record since May 20, 2026
- Director at Cara Therapeutics, Inc. · on record since Jan 31, 2014
- 10% owner at Cara Therapeutics, Inc. · on record since Jan 31, 2014
- Director at APPLIED GENETIC TECHNOLOGIES CORP · on record since Mar 26, 2014
- Director at DYNEGY INC /IL/ · on record since Jun 9, 2026
- 10% owner at DYNEGY INC /IL/ · on record since Sep 23, 2020
- Chief Financial Officer at TURMERIC ACQUISITION CORP. · on record since Oct 15, 2020
- 10% owner at COTHERIX INC · on record since Oct 14, 2005
Insider trading activity of HURWITZ EDWARD
- Transactions on record
- 136
- since Apr 7, 2009
- Open-market buys
- 4
- $1.3M
- Open-market sells
- 22
- $19.6M
- Companies traded
- 7
- last filing Jun 9, 2026
Figures computed from official regulatory filings — methodology.
Companies where HURWITZ EDWARD has traded
Track record of HURWITZ EDWARD
Statistical track record
Free- Open-market buys
- 16
- Last buy
- Aug 30, 2023
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of HURWITZ EDWARD
Co-insiders of HURWITZ EDWARD
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Aegerion Pharmaceuticals, Inc. +5
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 9, 2026 | AwardD | 35,152 | 0.00 USD | $0 | SEC |
| May 20, 2026 | AwardD | 3,750 | 0.00 USD | $0 | SEC |
| May 20, 2026 | AwardD | 22,000 | 0.00 USD | $0 | SEC |
| May 20, 2026 | ExerciseD | -3,750 | 0.00 USD | $0 | SEC |
| May 20, 2026 | Exercise | 3,750 | — | — | SEC |
| Jun 3, 2025 | AwardD | 35,000 | 0.00 USD | $0 | SEC |
| May 22, 2025 | ExerciseD | -6,500 | 0.00 USD | $0 | SEC |
| May 22, 2025 | AwardD | 22,000 | 0.00 USD | $0 | SEC |
| May 22, 2025 | AwardD | 3,750 | 0.00 USD | $0 | SEC |
| May 22, 2025 | Exercise | 6,500 | — | — | SEC |
| May 24, 2024 | AwardD | 25,133 | 0.00 USD | $0 | SEC |
| May 23, 2024 | AwardD | 6,500 | 0.00 USD | $0 | SEC |
| May 23, 2024 | AwardD | 16,500 | 0.00 USD | $0 | SEC |
| May 22, 2024 | ExerciseD | -4,500 | 0.00 USD | $0 | SEC |
| May 22, 2024 | Exercise | 4,500 | 0.00 USD | $0 | SEC |
| Sep 1, 2023 | Buy | 15,000 | 4.91 USD | $73.7K | SEC |
| Jun 2, 2023 | AwardD | 19,000 | 0.00 USD | $0 | SEC |
| Jun 2, 2023 | AwardD | 4,500 | 0.00 USD | $0 | SEC |
| May 25, 2023 | AwardD | 24,900 | 0.00 USD | $0 | SEC |
| Dec 1, 2022 | OtherD | -9,375 | — | — | SEC |
| Dec 1, 2022 | OtherD | -14,000 | — | — | SEC |
| Dec 1, 2022 | OtherD | -6,200 | — | — | SEC |
| Dec 1, 2022 | OtherD | -10,000 | — | — | SEC |
| Dec 1, 2022 | OtherD | -4,688 | — | — | SEC |
| Dec 1, 2022 | OtherD | -12,000 | — | — | SEC |